arrow
返回

A physical basis for quantitative ChIP-sequencing

delete2020-11-01
delete13
delete
OA
AI
B
Bradley M. Dickson *
R
Rochelle L. Tiedemann
A
Alison A. Chomiak
E
Evan M. Cornett
R
Robert M. Vaughan
S
Scott B. Rothbart
DOI:10.1074/jbc.RA120.015353delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
ChIP followed by next-generation sequencing (ChIP-Seq) is a key technique for mapping the distribution of histone posttranslational modifications (PTMs) and chromatin-associated factors across genomes. There is a perceived challenge to define a quantitative scale for ChIP-Seq data, and as such, several approaches making use of exogenous additives, or spike-ins, have recently been developed. Herein, we report on the development of a quantitative, physical model defining ChIP-Seq. The quantitative scale on which ChIP-Seq results should be compared emerges from the model. To test the model and demonstrate the quantitative scale, we examine the impacts of an EZH2 inhibitor through the lens of ChIP-Seq. We report a significant increase in immunoprecipitation of presumed off-target histone PTMs after inhibitor treatment, a trend predicted by the model but contrary to spike-in-based indications. Our work also identifies a sensitivity issue in spike-in normalization that has not been considered in the literature, placing limitations on its utility and trustworthiness. We call our new approach the sans-spike-in method for quantitative ChIP-sequencing (siQ-ChIP). A number of changes in community practice of ChIP-Seq, data reporting, and analysis are motivated by this work.
Keyword:
ChIP-Seq
ChIP normalization
quantitative ChIP
antibody specificity
ChIP-sequencing
epigenetics
biophysics
chromatin immunoprecipitation (ChiP)
mathematical modeling
quantitative ChIP-Seq
spike-in
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Journal of Biological Chemistry 封面图
Journal of Biological Chemistry
IF:
3.9
论文数:
11.2W
被引数:
28.3W

机构

V
van andel institute
学者数:
1.8K
论文数: 1.1K
被引数: 16
引用论文

引用论文

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2通过抑制甲基转移酶EZH2在遗传改变的恶性横纹肌样瘤中持久的肿瘤消退
err2013-04-25
err709
errOAAI
errKnutson, Sarah K.; Warholic, Natalie M.; Wigle, Tim J.; Klaus, Christine R.; Allain, Christina J.; Raimondi, Alejandra; Scott, Margaret Porter; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.; Richon, Victoria M.; Pollock, Roy M.; Kuntz, Kevin W.; Keilhack, Heike
err分享
err收藏
A Randomized Controlled Trial of Brief Motivational Interviewing in Impaired Driving Recidivists: A 5‐Year Follow‐Up of Traffic Offenses and Crashes
err2013-07-29
err0
errOAAI
errMarie Claude Ouimet; Maurice Dongier; Ivana Di Leo; Lucie Legault; Jacques Tremblay; Florence Chanut; Thomas G. Brown
err分享
err收藏
Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies
err2018-10-01
err80
errOAAI
errShah, Rohan N.; Grzybowski, Adrian T.; Cornett, Evan M.; Johnstone, Andrea L.; Dickson, Bradley M.; Boone, Brandon A.; Cheek, Marcus A.; Cowles, Martis W.; Maryanski, Danielle; Meiners, Matthew J.; Tiedemann, Rochelle L.; Vaughan, Robert M.; Arora, Neha; Sun, Zu-Wen; Rothbart, Scott B.; Keogh, Michael-Christopher; Ruthenburg, Alexander J.
err分享
err收藏
Native internally calibrated chromatin immunoprecipitation for quantitative studies of histone post-translational modifications
err2019-11-13
err16
errOAAI
errGrzybowski, Adrian T.; Shah, Rohan N.; Richter, William F.; Ruthenburg, Alexander J.
err分享
err收藏
err分享
err收藏
Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis
err2023-03-09
err0
errOAAI
errTuan Vu; Stephan Ortiz; Masahisa Katsuno; Djillali Annane; Renato Mantegazza; Kathleen N. Beasley; Rasha Aguzzi; James F. Howard
err分享
err收藏
学者 查看更多内容